Cell Movement Evaluation for Neurological Disease Research
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack an effective evaluation system for understanding the onset mechanisms and pathologic conditions of central nervous system diseases like schizophrenia and autism spectrum disorder, particularly in relation to dopamine neurons and Reelin expression, which is crucial for developing therapeutic approaches.
Innovation Solution
A cell-based assay system using induced pluripotent stem cells to evaluate the movement patterns of dopamine neurons, where the directional movement ability of individual cells is used as an index to assess disease states and drug efficacy or toxicity, by culturing cells in the presence of test substances and analyzing their movement patterns over time.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional cell-based assays are used to study neurodevelopmental disorders, then general cell population analysis is possible, but specific evaluation of neuronal migration abnormalities and drug effects on individual cell movement cannot be achieved
Solution Approach 1:
The patent divides the cell population into individual trackable cells, analyzing movement patterns of each cell separately rather than as a bulk population. This segmentation enables precise measurement of directional movement ability at the single-cell level, revealing abnormalities in neuronal migration that would be invisible in conventional population-level assays.
Solution Approach 2:
The patent replaces conventional mechanical/visual cell assessment methods with automated image analysis and computational tracking systems. By using computer-based algorithms to track cell positions and calculate movement parameters (displacement, directionality, speed), the system achieves high-precision measurement without manual intervention, resolving the contradiction between precision and complexity.
2Measurement precision
If detailed movement pattern analysis of individual cells is implemented, then accurate detection of disease-related migration defects is possible, but the complexity and time required for analysis increases
Solution Approach 1:
The patent pre-programs automated tracking algorithms and establishes measurement protocols before experiments begin. Cell movement is continuously recorded and analyzed in real-time or near-real-time using predetermined computational methods, eliminating the need for manual frame-by-frame analysis after data collection. This preliminary setup of automated systems dramatically reduces post-experiment analysis time while maintaining high detection accuracy.
Solution Approach 2:
The patent uses digital image copies and computational models to represent actual cell movements. Instead of directly manipulating or manually analyzing physical cells, the system creates digital representations of cell positions and trajectories, which can be processed rapidly by computers. This copying approach enables accurate detection of movement patterns without the time-consuming nature of direct manual observation.
3Adaptability or versatility
If a comprehensive evaluation system for neuronal movement is developed, then both basic research and drug evaluation applications become possible, but the system complexity and implementation difficulty increase
Solution Approach 1:
The patent designs a unified evaluation system that serves multiple functions: basic research on neuronal migration mechanisms, disease model validation, and drug screening/evaluation. The same core technology (automated cell tracking and movement parameter analysis) is applied across all these applications, eliminating the need for separate specialized systems for each purpose. This universal approach increases adaptability while managing system complexity through technology reuse.
Solution Approach 2:
The patent introduces a standardized movement parameter framework as an intermediary layer between diverse research applications and the underlying tracking technology. By defining universal metrics (displacement, directionality coefficient, speed) that can quantify different aspects of cell movement, the system enables various applications to interface with a common analytical platform, reducing implementation difficulty across different use cases.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
An object of the present invention is to provide a novel evaluation system that is particularly useful in researches on the onset mechanism and pathologic conditions of a central nervous system disease, development of a therapeutic method, or the like. The efficacy of a test substance is evaluated using a movement pattern defined by variations in movement of individual cells constituting a cell population as an index.